NCT02302599View on ClinicalTrials.gov

Mesenchymal Stem Cells to Treat Type 2 Diabetes

PHASE2CompletedINTERVENTIONAL
Enrollment

103

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Type 2 DiabetesMesenchymal Stem Cells
Interventions
BIOLOGICAL

Umbilical cord mesenchymal stem cells

Infusion treatment

BIOLOGICAL

Controlled suspension liquid

Infusion treatment

Trial Locations (1)

100039

Chinese PLA General Hospital, Beijing

All Listed Sponsors
lead

Chinese PLA General Hospital

OTHER

NCT02302599 - Mesenchymal Stem Cells to Treat Type 2 Diabetes | Biotech Hunter | Biotech Hunter